Nel ASA's Unanswered Questions Mount as CEO Exit Compounds a Bruising Quarter

Nel ASA faces leadership vacuum, mixed Q2 results, and sell-side skepticism as order backlog grows but losses deepen.

The departure of Nel ASA's chief executive has left Norway's hydrogen equipment maker in an awkward holding pattern. With no successor named, investors are forced to weigh a leadership vacuum against a set of quarterly numbers that offered something for both bulls and bears — and a wall of analyst skepticism that shows no signs of cracking.

The timing could hardly be more awkward. Just over three weeks ago, the company posted second-quarter 2026 results that painted a genuinely mixed picture. Order intake surged 224% year-on-year to 230 million Norwegian kroner, yet revenue from customer contracts fell 12% and EBITDA swung to a loss of 155 million kroner. The net loss for the quarter came in at 189 million kroner, a figure that includes the 70 million kroner settlement paid to resolve the legal dispute with Iwatani Corporation of America. The order backlog stood at roughly 1.2 billion kroner at the end of the period.

That combination — a swelling order book alongside shrinking revenue and deepening losses — has kept observers on edge. The settlement with Iwatani, disclosed around the same time as the earnings, added another layer of friction; since that news broke, the shares have shed a further 2.0%.

The leadership change now threatens to overshadow the operational narrative entirely. A company already wrestling with soft market conditions, restructuring pressure and persistent losses now faces a period of uncertainty at the top, precisely when it needs to convince investors that its growing pipeline of orders can actually translate into revenue and profit. Media commentary has been blunt, with some outlets describing a full-blown leadership crisis.

The sell-side is hardly rushing to the stock's defense. A survey of 14 analysts published just over a week ago produced a consensus rating of "Sell," with a twelve-month price target of 2.08 Norwegian kroner. That dovetails with JPMorgan's decision, announced roughly three weeks ago, to cut its price target to 1.80 kroner from 2.90 kroner while holding a "Neutral" rating. No fresh analyst opinion has emerged since, leaving that cautious stance as the prevailing voice on the Street. Since the JPMorgan revision, the stock has given up another 1.2%.

The balance sheet adds its own note of caution. Cash reserves stood at 1.33 billion kroner at the end of the second quarter, down sharply from 1.93 billion kroner a year earlier — a reminder that the company's financial runway is shortening even as it pursues growth.

Technical indicators offer little comfort. The shares closed at 0.1938 euros, down 1.1% on the day, and now trade roughly 5.0% below their 50-day moving average. One automated technical model has issued only a "Hold/Accumulate" signal, noting that the stock has fallen 10% since a sell signal emerged in mid-August. The relative strength index sits at 40.3, a neutral-to-slightly-oversold reading that suggests no clear directional bias. The distance to the 52-week high of 0.3655 euros, reached in May, stands at 47%, while the stock trades 9.1% below its 200-day average of 0.2141 euros — a sign that the medium-term trend remains pointed downward.

Still, the picture is not uniformly bleak. The shares are up 3.1% since the start of the year, indicating that the recent softness has eroded but not erased earlier gains. Market capitalization currently stands at around 359 million euros.

The near-term catalysts are clear. Nel is scheduled to publish its third-quarter interim report on October 21, which should reveal whether the EU funding decision announced about three weeks ago is beginning to show up in operations and whether the order pipeline is stabilizing. But for now, the more pressing question is who will actually lead the company through that reporting season — and beyond. Until the board resolves the succession question, the stock remains vulnerable to further setbacks, even with a backlog that provides genuine substance for the quarters ahead.